Search - tctmd.com

Displaying 1 - 20 of 138

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Dietary Salt Linked to AF Risk in Patients With Vascular Disease or Diabetes

L.A. McKeown

July 11, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

L.A. McKeown

May 24, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Daily News

Optimal Care Reported in Less Than Half of Adults With ASCVD

Yael L. Maxwell

December 05, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

What’s Going to Be Hot at ACC 2025?

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Dietary Salt Linked to AF Risk in Patients With Vascular Disease or Diabetes

July 2024 Dispatch for the CV Team

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

What’s Going to Be Hot at ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

GDMT Rates Low in HFrEF, Particularly in Women

Optimal Care Reported in Less Than Half of Adults With ASCVD

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content